Pharmaceuticals

Drug Development Drug Pricing Drug Approval Drug Safety Weight Loss Drugs Clinical Trials Prescription Drugs Drug Manufacturing Drug Regulation Prescription Medications

Regeneron Beats Q4 and Charts 2026 Catalysts With FDA Decisions and Phase III Push

Analyst revisions signal a clearer 2026 growth path.

Lilly Signs Up to $1.12 Billion Gene-Editing Pact to Tackle Hearing Loss

Roche Posts 2025 CER Growth but Misses Profit Forecast as Strong Franc Weighs

EMA Panel Backs Conditional EU Approval for Rezurock in Chronic GvHD

AstraZeneca Pledges $15 Billion China Expansion Through 2030

FDA Grants Priority Review to Otsuka’s ADHD Drug Centanafadine With July 24 Decision Date

Florida Senate Panel Advances Bill To Expand Vaccine Opt-Outs, Loosen Ivermectin Rules

Merck Ends Revolution Medicines Takeover Talks After Valuation Standoff

Abbott Slips on Q4 Revenue Miss as 2026 Outlook Points to Reacceleration

Moderna, Merck Melanoma Vaccine Shows Durable Five-Year Benefit as Stock Hits 52-Week High

J&J Beats Q4 Forecasts and Sets 2026 Guidance Above Wall Street

Corvus Leaps After Soquelitinib Shows Strong Phase 1 Cohort 4 Eczema Data

Wall Street Sees 175% Upside for Viking Therapeutics on Obesity Drug Bet

Merck Lifts Mid-2030s Revenue Goal to $70 Billion From Emerging Businesses

Florida HIV Drug Program Cuts Draw Capitol Protests Ahead of March 1

Three Charged in Targeted Robbery of $16,000 in GLP-1 Drugs at Bensalem Pharmacy

Republicans Press Trump Administration to Halt Mail-Order Abortion Pills Crossing State Lines

Strive Compounding Sues Lilly and Novo, Alleging Antitrust Push to Block Compounded GLP-1s

Chicago Nurse Pleads Not Guilty to Federal Charges Over Counterfeit ‘Ozempic’ Injections

Samsung Epis Targets 20 Biosimilars by 2030, Adds Six Candidates and Readies First ADC Trial